![Robert Clayton Fletcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Clayton Fletcher
Corporate Officer/Principal bei
BIOCRYST PHARMACEUTICALS, INC.
Profil
Robert Clayton Fletcher currently works at BioCryst Pharmaceuticals, Inc., as Chief Business Development Officer from 2023.
Mr. Fletcher also formerly worked at Centocor, Inc., as Senior Associate Scientist from 1991 to 1993, Idera Pharmaceuticals, Inc., as SVP-Business Development & Strategic Planning from 2015 to 2020, Smithkline Beecham Plc, as Senior Project Manager from 1997 to 2001, Shire ViroPharma, Inc., as VP-Business Development & Project Management from 2001 to 2014, and Viropharma, Inc., as VP-Business Development & Project Management from 2005 to 2014.
Mr. Fletcher received his graduate degree in 1990 from Wake Forest University and undergraduate degree in 1985 from Wake Forest University.
Aktive Positionen von Robert Clayton Fletcher
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2023 |
Ehemalige bekannte Positionen von Robert Clayton Fletcher
| Unternehmen | Position | Ende |
|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | 31.12.2020 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01.01.2014 |
Viropharma, Inc. | Corporate Officer/Principal | 01.01.2014 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2001 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | 01.01.1993 |
Ausbildung von Robert Clayton Fletcher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viropharma, Inc. |
